Patent · US Active

Predictive markers for ovarian cancer

US9274118B2 · kind B2 · utility

4Cited by
56References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 4, 2014
Grant dateMar 1, 2016
Priority date
Expiry dateFeb 4, 2034

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A90/10
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Methods are provided for predicting the presence, subtype and stage of ovarian cancer, as well as for assessing the therapeutic efficacy of a cancer treatment and determining whether a subject potentially is developing cancer. Associated test kits, computer and analytical systems as well as software and diagnostic models are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.